Form 4 for PHAT Phathom Pharmaceuticals, Inc.
Accepted 2026-03-11 00:00:00 ET · period of report 2026-03-10 · accession 0001193125-26-102632 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-03-11 | 2026-03-10 | PHAT | Parikh Asit | Dir | G - Gift | $0.00 | +40.0K | 120.5K | +50% | $0 |
| 2026-03-11 | 2026-03-10 | PHAT | Parikh Asit | Dir | G - Gift | $0.00 | -40.0K | 10.5K | -79% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-10 | G | A | 40,000 | $0.00 | 120,500 | I | — | — | (F1) Reflects shares transferred for no consideration to a trust for the benefit of the Reporting Person's spouse and for which the Reporting Person serves as trustee. |
| 2 | Common | Common Stock | 2026-03-10 | G | D | 40,000 | $0.00 | 10,500 | D by Trust | — | — |